Home Evidence of fetal pulmonary aspiration of intra-amniotic administered surfactant in animal experiment
Article
Licensed
Unlicensed Requires Authentication

Evidence of fetal pulmonary aspiration of intra-amniotic administered surfactant in animal experiment

  • R. Illia , C. Solana , P. Oliveri , J. Toblli , M.U. Imaz and D. Häbich
Published/Copyright: June 1, 2005
Journal of Perinatal Medicine
From the journal Volume 32 Issue 4

Abstract

Introduction: The instillation of surfactant into the airways of patients with respiratory distress syndrome (RDS), especially in the neonatal period, is a proven therapy. The preventive therapy of RDS through intra-amniotic injection of surfactant has been reported recently. It has not been conclusively shown, however, that the surfactant administered in this way actually reaches the fetal pulmonary airways.

Objective: To study the distribution in fetal organs of a natural surfactant labeled with technetium-99m and injected through amniocentesis into the amniotic sac of guinea pigs in the last third of pregnancy.

Methods: After stimulating fetal respiratory movements with aminophylline 0.3 ml of an aqueous suspension containing 0.75 mg of phospholipids of a natural bovine surfactant labeled with technetium-99m, together with 0.1 ml of the biological dye carmine indigo, were injected into the amniotic sac. One hour later fetuses were delivered by cesarean section. In those that were dye-stained, dosimetric and gammagraphic tests were applied to trachea, lungs, esophagus, stomach, heart, liver, kidneys and placenta.

Results: Significant radio isotopic activity was found in both lungs of six treated fetuses, with a dose capture of between 1.0% and 5.3% of total dose. The level of activity in the stomachs was similar to that in the lungs (0.9% to 3.0% dose capture), whereas activity in other organs was negligible except in two placentae. No radio isotopic activity was found in non-injected control fetuses.

Conclusions: In the present animal model natural surfactant injected intra-amniotically is aspirated into the lungs within one hour.

:
Published Online: 2005-06-01
Published in Print: 2004-07-09

Copyright © 2004 by Walter de Gruyter GmbH & Co. KG

Articles in the same Issue

  1. Publishers' note
  2. ‘Fetal programming’ and ‘functional teratogenesis’: on epigenetic mechanisms and prevention of perinatally acquired lasting health risks
  3. The baby or the bathwater: which one should be discarded?
  4. Waterbirths compared with landbirths: an observational study of nine years
  5. Anti-hypertensive therapy and the feto-placental circulation: effects on umbilical artery resistance
  6. A 2 hour versus the 3 hour 100 g glucose tolerance test for diagnosing gestational diabetes mellitus
  7. Mycoplasma hominis in mid-trimester amniotic fluid: relation to pregnancy outcome
  8. Changes in the size of maternal inferior vena cava during pregnancy
  9. Maternal plasma procalcitonin concentrations in patients with preterm labor and intact membranes - prediction of preterm delivery and admission-to-delivery interval
  10. Determinant factors in Ecuador related to pregnancy among adolescents aged 15 or less
  11. Different maternal serum hCG levels in pregnant women with female and male fetuses: does fetal hypophyseal – adrenal – gonadal axis play a role?
  12. Behavioral pattern continuity from prenatal to postnatal life a study by four-dimensional (4D) ultrasonography
  13. Evidence of fetal pulmonary aspiration of intra-amniotic administered surfactant in animal experiment
  14. Impact of phototherapy on vasoactive mediators: NO and VEGF in the newborn
  15. Reexpansion pulmonary edema following patent ductus arteriosus ligation in a preterm infant
  16. Prostaglandin E[1] treatment in patent ductus arteriosus dependent congenital heart defects
  17. Maternal anaphylaxis and fetal brain damage after intrapartum chemoprophylaxis
  18. Atypical sonographic presentation of fetal unilateral inguinoscrotal hernia in a multiple gestation
  19. A case report of polysplenia syndrome associated with genital tract duplication anomaly
  20. Hyperphenylalaninemia in a premature infant with heterozygosity for phenylketonuria
Downloaded on 31.10.2025 from https://www.degruyterbrill.com/document/doi/10.1515/JPM.2004.066/html
Scroll to top button